---
company: Alto Ingredients, Inc.
ticker: ALTO
form: 8-K
filed: 2026-08-05
accession: 0001213900-26-085686
source: https://www.sec.gov/Archives/edgar/data/778164/000121390026085686/
---

# Alto Ingredients (ALTO) earnings release, August 5, 2026

Alto Ingredients, Inc. (ALTO) · Form 8-K, Item 2.02 · Filed 2026-08-05 · [SEC filing](https://www.sec.gov/Archives/edgar/data/778164/000121390026085686/)

Alto

Ingredients, Inc. Reports Second Quarter 2026 Results

Q2

2026 Gross Profit of $16.6 Million Increased $18.6 Million

Q2 2026 Net Income of $11.4 Million, or $0.15 per Share, Improved $22.7 Million

Q2 2026 Adjusted EBITDA of $23.7 Million Improved $23.9 Million

Pekin,

Ill., August 5, 2026 – Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of renewable fuels, essential ingredients and specialty alcohols, reported its financial results for the quarter ended June 30, 2026.

“Alto’s second quarter results mark the fourth consecutive quarter of positive gross profit, income from operations, net income and adjusted

EBITDA. We have maintained consistent profitability over this period even before the contribution of earnings from 45Z tax credits. These results demonstrate the benefits of our diversification strategy, which gives us the flexibility to shift production toward the most attractive end markets and capture premium-value opportunities,” said President and Chief Executive Officer Bryon McGregor.

“Having begun a strategic realignment three years ago, we now have a diversified product portfolio, a leaner cost structure and an operating model capable of generating positive adjusted EBITDA through commodity cycles while providing meaningful upside when market conditions are favorable,” added Mr. McGregor. “In addition, we have numerous initiatives in process and ahead of us to expand capacity, optimize CO² production, improve efficiencies and increase our earnings from 45Z tax credits.”

Mr.

McGregor concluded, “Our second quarter and latest 12-month financial results, combined with our ability to execute on high-return opportunities, reinforce our confidence in Alto’s ability to generate sustainable earnings and create long-term shareholder value.”

Rob

Olander, Chief Financial Officer, added that, “Today, we established a $50 million at-the-market equity program. Alongside our available borrowing capacity and operating cash flow, the ATM program provides additional financial flexibility and a prudent, low-cost tool to effectively access equity capital. We see a number of attractive, high-return organic opportunities across our platform. Having the ATM program in place allows us to remain prepared to pursue those opportunities when expected returns, market conditions and shareholder interests align. Any use of the program would be disciplined, measured and evaluated against other sources of available capital.”

Financial

Results for the Three Months Ended June 30, 2026 Compared to 2025¹

Cash and cash equivalents at June 30, 2026 were $24.0 million, compared to $23.4 million at December 31, 2025. The company’s borrowing availability at June 30, 2026 was $106 million, including $41 million under the company’s operating line of credit and $65 million under its term loan facility.

Second

Quarter 2026 Results Conference Call

Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Wednesday, August 5, 2026, and will deliver prepared remarks via webcast followed by a question-and-answer session.

To receive a number and unique PIN by email, register here. To dial directly up to 20 minutes prior to the scheduled call time, please dial (833) 630-0017 domestically and (412) 317-1806 internationally. Alternatively, the webcast for the conference call can be accessed from Alto Ingredients’ website at www.altoingredients.com and will be available for one year.

Use of Non-GAAP Measures

Management believes that certain financial measures not in accordance with generally accepted accounting principles (“GAAP”) are useful measures of operations. The company defines Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, provision (benefit) for income taxes, asset impairments, unrealized derivative gains and losses, acquisition-related expense, excess insurance proceeds and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company’s performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool, and you should not consider this measure in isolation or as a substitute for analysis of the company’s results as reported under GAAP.²

About

Alto Ingredients, Inc.

Alto

Ingredients, Inc. (NASDAQ: ALTO) is a leading producer and distributor of renewable fuels, essential ingredients and specialty alcohols.

Leveraging the unique qualities of its facilities, the company serves customers in a wide range of consumer and commercial products in the Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. For more information, please visit www.altoingredients.com.

Safe

Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward-looking statements generally will be accompanied by words... (t “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,”

“expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,”

“might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning

Alto Ingredients’ expectations around expanding production capacity; profitability and executing on opportunities to grow earnings, including through improved utilization and reliability, optimization and capital projects, and monetizing additional Section 45Z tax credits; the use and benefits of its ATM program, including returns that Alto Ingredients may generate from using funds, if any, from the program to make capital investments; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business and plans. These factors include, among others, adverse economic and market conditions, including for renewable fuels, specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; adverse impacts of inflation and supply chain constraints, including from tariffs; prevailing market prices and trading volumes of Alto Ingredients’ stock; Alto Ingredients’ ability, if desirable, to execute on its ATM program; Alto Ingredients’ ability to timely and within budget execute on its optimization and capital projects; regulatory developments and Alto Ingredients’ ability to successfully pursue and secure opportunities, and realize the expected results, under existing and new legislation, including the Section 45Z regulations, and to successfully apply for and receive anticipated credit amounts. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the alcohol production, marketing and distribution industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ facilities, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8,

2026.

Company

IR and Media Contact:

Michael

Kramer, Alto Ingredients, Inc., 916-403-2755

Investorrelations@altoingredients.com

IR

Agency Contact:

Jody

Burfening, Alliance Advisors Investor Relations, 212-838-3777,

Investorrelations@altoingredients.com³

ALTO

## Financial statements

### Income Statement (Three Months Ended June 30, — (unaudited, in thousands, except per share data))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Net sales | 245,698 | 218,436 | 470,378 | 444,976 |
| Cost of goods sold | 229,062 | 220,373 | 444,523 | 448,720 |
| Gross profit (loss) | 16,636 | -1,937 | 25,855 | -3,744 |
| Selling, general and administrative expenses | 8,017 | 6,171 | 14,716 | 13,361 |
| Income (loss) from operations | 8,619 | -8,108 | 11,139 | -17,105 |
| Interest expense, net | -1,960 | -2,811 | -4,158 | -5,540 |
| Transferable tax credits, net | 5,112 |  | 9,012 |  |
| Other expense, net | -70 | -78 | -21 | -31 |
| Income (loss) before provision for income taxes | 11,701 | -10,997 | 15,972 | -22,676 |
| Net income (loss) | 11,701 | -10,997 | 15,972 | -22,676 |
| Preferred stock dividends | -315 | -315 | -627 | -627 |
| Net income (loss) attributable to common stockholders | 11,386 | -11,312 | 15,345 | -23,303 |
| Net income (loss) per share, basic | 0.15 | -0.15 | 0.2 | -0.31 |
| Net income (loss) per share, diluted | 0.15 | -0.15 | 0.2 | -0.31 |
| Weighted-average shares outstanding, basic | 75,588 | 74,611 | 75,191 | 74,232 |
| Weighted-average shares outstanding, diluted | 77,071 | 74,611 | 76,609 | 74,232 |

### Income Statement (Three Months Ended June 30, — Reconciliation of Adjusted EBITDA to Net Income (Loss) (in thousands))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Net income (loss) | 11,701 | -10,997 | 15,972 | -22,676 |
| Adjustments: | Interest expense | 1,960 | 2,811 | 4,158 | 5,540 |
| Adjustments: | Interest income | -87 | -67 | -165 | -150 |
| Adjustments: | Unrealized derivative losses (gains) | 3,634 | 2,117 | -4,439 | 483 |
| Adjustments: | Acquisition-related income |  | -460 |  | -460 |
| Adjustments: | Depreciation and amortization expense | 6,452 | 6,365 | 12,819 | 12,631 |
| Adjustments: | Total adjustments | 11,959 | 10,766 | 12,373 | 18,044 |
| Adjustments: | Adjusted EBITDA | 23,660 | -231 | 28,345 | -4,632 |

### Income Statement (Three Months Ended June 30, — Segment Financials (in thousands) (unaudited))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Pekin Campus production: | Alcohol sales | 114,370 | 94,155 | 222,321 | 201,390 |
| Pekin Campus production: | Essential ingredient sales | 45,071 | 39,565 | 89,064 | 84,183 |
| Pekin Campus production: | Intersegment sales | 229 | 183 | 492 | 481 |
| Pekin Campus production: | Total Pekin Campus sales | 159,670 | 133,903 | 311,877 | 286,054 |
| Marketing and distribution: | Alcohol sales, gross | 54,612 | 58,106 | 101,889 | 107,101 |
| Marketing and distribution: | Alcohol sales, net | 60 | 80 | 109 | 142 |
| Marketing and distribution: | Intersegment sales | 2,512 | 2,334 | 4,962 | 4,840 |
| Marketing and distribution: | Total marketing and distribution sales | 57,184 | 60,520 | 106,960 | 112,083 |
| Western production: | Alcohol sales | 20,798 | 16,604 | 37,479 | 32,798 |
| Western production: | Essential ingredient sales | 8,843 | 8,250 | 16,123 | 16,058 |
| Western production: | Intersegment sales | 449 | 505 | 848 | 769 |
| Western production: | Total Western production sales | 30,090 | 25,359 | 54,450 | 49,625 |
| Western production: | Corporate and other | 1,944 | 1,676 | 3,393 | 3,304 |
| Western production: | Intersegment eliminations | -3,190 | -3,022 | -6,302 | -6,090 |
| Western production: | Net sales as reported | 245,698 | 218,436 | 470,378 | 444,976 |
| Cost of goods sold: | Pekin Campus production | 148,148 | 139,748 | 292,918 | 294,974 |
| Cost of goods sold: | Marketing and distribution | 53,404 | 56,518 | 99,442 | 104,167 |
| Cost of goods sold: | Western production | 27,955 | 23,501 | 52,707 | 49,024 |
| Cost of goods sold: | Corporate and other | 1,010 | 1,705 | 2,046 | 3,386 |
| Cost of goods sold: | Intersegment eliminations | -1,455 | -1,099 | -2,590 | -2,831 |
| Cost of goods sold: | Cost of goods sold as reported | 229,062 | 220,373 | 444,523 | 448,720 |
| Gross profit (loss): | Pekin Campus production | 11,522 | -5,845 | 18,959 | -8,920 |
| Gross profit (loss): | Marketing and distribution | 3,780 | 4,002 | 7,518 | 7,916 |
| Gross profit (loss): | Western production | 2,135 | 1,858 | 1,743 | 601 |
| Gross profit (loss): | Corporate and other | 934 | -29 | 1,347 | -82 |
| Gross profit (loss): | Intersegment eliminations | -1,735 | -1,923 | -3,712 | -3,259 |
| Gross profit (loss): | Gross profit (loss) as reported | 16,636 | -1,937 | 25,855 | -3,744 |

### Balance Sheet (June 30, 2026 — ALTO INGREDIENTS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, in thousands, except par value))

| | June 30, 2026 | December 31, 2025 |
|---|---:|---:|
| Current Assets: | Cash and cash equivalents | 23,962 | 23,415 |
| Current Assets: | Restricted cash |  | 2,258 |
| Current Assets: | Accounts receivable, net | 67,889 | 55,069 |
| Current Assets: | Inventories | 51,609 | 61,676 |
| Current Assets: | Transferable tax credits, net | 8,265 | 7,500 |
| Current Assets: | Derivative instruments | 4,173 | 525 |
| Current Assets: | Other current assets | 4,926 | 5,474 |
| Current Assets: | Total current assets | 160,824 | 155,917 |
| Current Assets: | Property and equipment, net | 197,479 | 198,501 |
| Other Assets: | Right of use operating lease assets, net | 21,492 | 16,931 |
| Other Assets: | Intangible assets, net | 7,264 | 7,574 |
| Other Assets: | Other assets | 10,011 | 9,863 |
| Other Assets: | Total other assets | 38,767 | 34,368 |
| Other Assets: | Total Assets | 397,070 | 388,786 |

### Balance Sheet (June 30, 2026 — ALTO INGREDIENTS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED) (unaudited, in thousands, except par value))

| | June 30, 2026 | December 31, 2025 |
|---|---:|---:|
| Current Liabilities: | Accounts payable | 24,219 | 14,509 |
| Current Liabilities: | Accrued liabilities | 16,424 | 16,691 |
| Current Liabilities: | Current portion – long-term debt |  | 16,600 |
